CEO MONTHLY / ISSUE 7 2024 18 As anybody who has ever suffered with migraines will attest to, they can be debilitating and impact dayto-day life immeasurably. With a name taken from the French work for headache, céphalée, as well as cephalic, a medical term meaning “for the head”, Cefaly Technology’s commitment to aiding those suffering from migraines is innate, unwavering, and ongoing. Thanks to a series of core values that guide its At its core, Cefaly Technology pioneers innovative, non-invasive solutions to measurably enhance the wellbeing and quality of life of individuals battling neurological disorders. Utilising leading-edge technology, underpinned by a commitment to advancing the field through research, it is the aim of this company to provide neurostimulation therapy that is safe, effective, and accessible. At the helm of this operation is Most Influential CEO 2024 - Greater New York (MedTech) recipient Jennifer Trainor McDermott, who we catch up with for more. operation, Cefaly today stands as a beacon of accessibility, education, and patient success in the field of MedTech. Jennifer Trainor McDermott is Cefaly’s CEO, and across her role, undertakes a number of responsibilities that all feed back to steering the company in the direction of its mission, to provide customers with innovative, non-pharmaceutical medical solutions. Another crucial element of Jennifer’s responsibilities involves nurturing a positive working environment and a highperforming team. Commenting on the strengths of the company’s workforce, Jennifer simply explains, “right now, Cefaly has the team that will carry us into the future.” Balancing empathy with understanding to both stay ahead of the curve and remain laser-focused on the human element of their solutions, this team strive to maintain good, strong relationships with everyone, from customers and fellow employees through to partners and investors. Key to achieving this has been the adoption of Jennifer’s “never say no” ethos, which allows the team to work together to overcome any obstacles that may be in their way, be it a new process or simply refusing to settle for what is already out there. This mindset has benefited Jennifer immeasurably across a career defined by pure tenacity and her investing in her own growth. Reflecting on her journey, Jennifer tells us, “I knew a long time ago I wanted to grow my career and be the best executive I could be. Nothing was ever handed to me. I had to work hard at every level of every organisation and prove every day that I could do more.” She continues, “but you always need to refine and expand your goals. I will never be done checking the box!” Such an attitude was instilled in Jennifer from a young age, and from a father with a powerful presence to a mother who raised her to make herself heard, as well as siblings who taught her that success is what you make it, Jennifer’s family have always been there for inspiration. The same is true of her husband, Stephen, and they both strive to set the same examples for their two children. Aside from her actual family, Jennifer’s work families have also proven essential, be it the team at the Estee Lauder Companies or her employees today at Cefaly. With this network supporting her, Jennifer is expertly guiding Cefaly through some of the challenges of operating in this industry, such as neuromodulation, the company’s primary area of operation, not being covered by medical insurance. Despite being out of pocket, the sheer amount of people seeking out these alternatives to traditional medicine is slowly spurring change. The same is true of those active in the military, who are campaigning for such solutions to come as standard so that they may replace the taking of pharmaceuticals. Constantly finding new and comprehensive ways to tackle these and other such challenges, pioneering female CEO Jennifer Trainor McDermott has already seen the company through the transition from a prescription model to an overthe-counter model, a global pandemic, and the endless task of serving a patient base that is constantly expanding. CeCe, the company’s one-way communication app, has been another highlight of her tenure, as too has the release of the company’s next-generation Bluetooth-enabled devices, Cefaly Connected. Harbouring no signs of slowing down, Jennifer states, “I want Cefaly to not only be the leader in the migraine device space, but also the leader in the neuromodulation space. We have huge plans to transform the sector!” For her ongoing commitment to this sphere, we are proud to name Jennifer Trainor McDermott as the Most Influential CEO 2024 - Greater New York (MedTech). Contact: Jennifer Trainor McDermott Company: Cefaly Technology Web Address: https://www. cefaly.co.uk/ Trailblazing Migraine Treatment and Prevention
RkJQdWJsaXNoZXIy MTUyMDQwMA==